Skip to main content
Caplight Logo









Remedio

Remedio

Private
Tel AvivCybersecurityhttps://remedio.io

Last Round

Series A

Sep 15, 2025

Est. Valuation

$300M

Total Funding Raised

$65M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Remedio operates in Cybersecurity and is based in Tel Aviv. Its latest recorded funding round was a Series A round in September 2025.

Remedio is a cybersecurity company that provides an AI-driven platform for device posture management, automated configuration hardening, and risk remediation.

Sector

Cybersecurity

Verticals

Endpoint Security, Vulnerability Management, Compliance & Risk, Identity & Access

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Remedio Comparables

Compare Remedio with similar companies based on industry and business-model similarity.

Remedio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Reach Security
74%
Microsoft
61%
Grip Security
51%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Remedio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 15, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Famidha Faims

Chief Executive Officer

Executive Team

Tal Kollender

Co-Founder & CEO, CISO

Founding Team

Matt Rowe

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Remedio Investors

Notable investors and investment history

Remedio investors
InvestorRounds
Picture CapitalSeries A
TLV PartnersSeries A
Bessemer Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Added DJ's Bail Bonds, a legal services startup, as a customer.

  • Apr 8, 2026

    Referenced Amazon, Colgate, and FIS as customers.

Book a demo to see all signals

For institutional investors. Book with your work email.

Remedio Filings

Explore SEC and related filing metadata, where available.

Remedio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Remedio's valuation, stock price, and market status.

Is Remedio a public or private company?

Remedio is a private company.

What is the current stock price of Remedio?

Remedio is a private company, so its shares have no public market price. Caplight tracks Remedio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Remedio worth (valuation)?

Remedio's valuation is estimated at $300.0M based on funding round data.

Can I buy Remedio stock?

Remedio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Remedio's last funding round?

Remedio's most recent funding round was Series A on September 15, 2025.

Who are the main investors in Remedio?

Key investors in Remedio include Bessemer Venture Partners.

Will Remedio IPO soon?

No public IPO plans have been announced for Remedio.

How can I track Remedio secondary market activity?

Caplight tracks bids, offers, and trades in Remedio's shares on secondary markets.

Firmographic Details

HeadquartersTel Aviv
Employee Range85
Year Founded2019
Last FundingSep 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?